ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Vasculitis"

  • Abstract Number: L12 • ACR Convergence 2024

    A-319, a CD3 X CD19 T Cell Engager (TCE), for the Treatment of Severe/Refractory SLE: Early Evidence of Rapid Reset of Disease-Specific Autoimmunity

    Chunli Mei1, Xin Guan1, Bin Wu2, Mengjiao Li1, Xiaojing Liu1, Xi Chen1, You Song1, Weiwei Wang1, Cheng Wang1, Huiling Mei1, Xiaoru Duan1, Lijuan Jiang1, Wenlin Qiu1, Likai Yu1, Yuhong Liu1, Xing Zhao3, Xuanfan Zhong3, Shengjie Xue3, Wuzhong Shen3, Ying Tan3, Guojian Yu3, Guiyun Tu3, Hanyang Chen3, Amy Sun3, Xiaoqiang Yan3, Anbing Huang1, Rong Du1 and Qiubai Li1, 1Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2Department of Rheumatology and Immunology of the First People’s Hospital of Jingzhou, Jingzhou, China, 3ITabMed Ltd. Changchun, Shanghai, China

    Background/Purpose: CD19 CAR T treatment has demonstrated clinical benefits to patients with severe/refractory systemic lupus erythematosus (SLE), possibly due to resetting autoimmunity. A-319, a highly…
  • Abstract Number: 0263 • ACR Convergence 2024

    Characteristics and Coinfections of Diffuse Alveolar Hemorrhage in Rheumatic Patients

    Eduardo Briones-García1, Shaul Navarro-Lara2, Marco A Ortiz-Bustamante2, Iris Paola García Herrera3, Carla M Roman-Montes2 and Guillermo A Guaracha-Basañez4, 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department., Ciudad de México, Distrito Federal, Mexico, 2Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador-Zubirán., México city, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion “Salvador Zubirán”, Mexico City, Distrito Federal, Mexico

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a severe respiratory complication observed in certain rheumatic diseases, such as systemic lupus erythematosus (SLE), ANCA-associated vasculitides (AAV), and…
  • Abstract Number: 0750 • ACR Convergence 2024

    Corticosteroid Withdrawal Using Tocilizumab and Its Association with Autoantibody Profile in Takayasu Arteritis: A Multicenter, Single-arm, Prospective Study

    Tsuyoshi Shirai1, Tomonori Ishii2, Soshi Okazaki1, Yuko Shirota3, Yusho Ishii4, Hiroko Sato1 and Hiroshi Fujii1, 1Tohoku University, Sendai, Japan, 2Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology, sendai, Japan, 3Tohoku University Hospital / Department of Hematology and Rheumatology, Sendai, Japan, 4Tohoku university, Sendai, Miyagi, Japan

    Background/Purpose: The application of molecular targeted drugs has been expanding in vasculitides. Takayasu arteritis (TAK) frequently relapses and tocilizumab (TCZ) and tumor necrosis factor inhibitors…
  • Abstract Number: 0827 • ACR Convergence 2024

    Oral Corticosteroid-Sparing Effects of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA): Results up to 7.4 Years from the Long-Term Access Programme

    Paneez Khoury1, Jared Silver2, Gerhard Wolff3, Robert Price4, Rejina Verghis5, Emmeline Igboekwe2 and Michael E Wechsler6, 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 2US Medical Affairs-Respiratory, GSK, Durham, 3Clinical Development-Respiratory, GSK, Collegeville, 4Biostatistics, GSK, Stevenage, United Kingdom, 5Biostatistics, Development Respiratory, GSK, Brentford, United Kingdom, 6Department of Medicine, National Jewish Health, Denver, CO

    Background/Purpose: EGPA is a severe, rare, relapsing/remitting inflammatory disease, in which chronic or high oral corticosteroid (OCS) doses lead to adverse effects, adding to disease…
  • Abstract Number: 1614 • ACR Convergence 2024

    Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry

    Juan Molina-Collada1, Marta Domínguez-Álvaro2, Rafael Benito Melero-Gonzalez3, Eugenio De Miguel4, Maite Silva-Diaz5, Jesús Alejandro Valero6, Ismael Gonzalez7, Julio Sánchez-Martín8, Javier Narvaez-García9, Joan Calvet10, Ivette Casafont-Solé11, José A Román Ivorra12, Selene Labrada-Arrabal13, Margarida Vasques Rocha:14, Carlota L Iñiguez:15, Maria Sagrario Bustabad Reyes16, Cristina Campos-Fernández17, María Alcalde Villar:18, Antonio Juan-Mas19 and Ricardo Blanco-Alonso20, and ARTESER Project Collaborative Group, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Sociedad Española de Reumatología, Madrid, Spain, 3CHU Ourense, O Carballino, Spain, 4Hospital Universitario La Paz, Madrid, Spain, 5Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, 6Hospital Universitario Donosti. Donostia, Spain, Donosti, Spain, 7Complejo Asistencial Universitario de Leon, León, Spain, 8Hospital Universitario 12 de Octubre, Madrid, Spain, 9Hospital Universitario de Bellvitge, Barcelona, Spain, 10Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA) (UAB), 08208 Sabadell, Spain, Barcelona, Spain, 11Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain, Barcelona, Spain, 12Hospital Universitari i Politècnic La Fe, Valencia, Spain, Valencia, Spain, 13Hospital del Mar, Barcelona, Spain, 14Hospital Universitario Araba, Vitoria, Spain, 15Hospital Universitario Lucus Augusti, Galicia, Spain, Galicia, Spain, 16Hospital Universitario de Canarias, La Laguna - Tenerife, Spain, 17Consorci Hospital General Universitari de València, Comunitat Valenciana, Spain, Valencia, Spain, 18Hospital Universitario Severo Ochoa Leganés, Madrid, Spain, Madrid, Spain, 19Hospital Universitari Son Llàtzer, Mallorca, Spain, 20Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: The question of survival in epidemiologic studies on giant cell arteritis (GCA) remains unclear to date, with notable heterogeneity in both the mortality rate…
  • Abstract Number: 1640 • ACR Convergence 2024

    ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis

    Eugenio De Miguel1, Iñigo Hernández-Rodríguez2, Maite Silva-Diaz3, Joaquin María Belzunegui:4, Patricia Moya5, Marina Tortosa-Cabañas6, Vanessa Andrea Navarro7, Joan Calvet8, Ivette Casafont-Solé9, Jose A Román-Ivorra10, Selene Labrada-Arrabal11, Margarida Vasques Rocha:12, Carlota L Iñiguez:13, Vanesa Hernández-Hernández14, Cristina Campos-Fernández15, María Alcalde Villar:16, Antonio Juan-Mas17, Francisco-Javier Prado-Galbarro18, Itziar Calvo19, Julio Sánchez-Martín20, Javier Narvaez-García21 and Ricardo Blanco-Alonso22, and ARTESER Project Collaborative Group, 1Hospital Universitario La Paz, Madrid, Spain, 2Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 3Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, 4H de Donostia, Donostia-San Sebasti, Spain, 5Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 6Hospital Universitario Ramón y Cajal, Madrid, Spain, 7Hospital Moisès Broggi, Sant Joan Despí, Spain, 8Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA) (UAB), 08208 Sabadell, Spain, Barcelona, Spain, 9Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain, Barcelona, Spain, 10Hospital Universitari i Politècnic la Fe, Valencia, Comunidad Valenciana, Spain, 11Hospital del Mar, Barcelona, Spain, 12Hospital Universitario Araba, Vitoria, Spain, 13Hospital Universitario Lucus Augusti, Galicia, Spain, Galicia, Spain, 14Hospital Universitario de Canarias, San Cristobal de La Laguna, Canarias, Spain, 15Consorci Hospital General Universitari de València, Comunitat Valenciana, Spain, Valencia, Spain, 16Hospital Universitario Severo Ochoa Leganés, Madrid, Spain, Madrid, Spain, 17Rheumatology Department, Hospital Universitario Severo Ochoa Leganés, Madrid, Spain, Madrid, Cantabria, Spain, 18Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-Unidad Xochimilco,, Mexico, Mexico, 19Hospital Universitario de Basurto, Bilbao, Spain, 20Hospital Universitario 12 de Octubre, Madrid, Spain, 21Hospital Universitario de Bellvitge, Barcelona, Spain, 22Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: The diagnosis of giant cell arteritis (GCA) has been guided for years by the ACR 1990 classification criteria but the emergence of the image…
  • Abstract Number: 2493 • ACR Convergence 2024

    Mortality in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: Study from a Single University Hospital

    Fabricio Benavides1, Alba Herrero-Morant2, Diana Prieto-Peña3, Vanesa Calvo-Rio4, Salma Al Fazazi5, Adrián Martín-Gutiérrez6, Mónica Renuncio-García7, Amparo Sánchez-López8, Claudia Poo-fernandez8, Clara Escagedo-Cagigas8, Maria Rodríguez-Vidriales1 and Ricardo Blanco-Alonso9, 1Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 2Hospital Universitario Marqués de Valdecilla, Ontinyent, Cantabria, Spain, 3Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 4Valdecilla Hospital, Santander, Cantabria, Spain, 5Hospital Universitario Virgen de la Victoria, Málaga, Andalucia, Spain, 6Hospital Universitario Marques de Valdecilla, IDIVAL, Renedo de Piélagos, Cantabria, Spain, 7Division of Immunology, Hospital Universitario Marqués de Valdecilla, Immunopathology Group, IDIVAL, Santander, Spain, 8Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 9Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) includes Granulomatosis with polyangiitis (GPA), Microscopic polyarteritis (MPA) and Eosinophilic granulomatosis with polyangiitis (EGPA). Due to clinical,…
  • Abstract Number: 2518 • ACR Convergence 2024

    Behçet’s Disease Immune Landscape Exhibits a Universal NF-kB-mediated Hyperactivation Pattern with Cell-specific TNFAIP3 Responses and a Superimposed IFN-regulated Endotype

    Yesim Ozguler1, Olivier Manches2, Didar Ucar3, Ziyan Lin2, Alireza Khodadadi-Jamayran2, Aristotelis Tsirigos2, Gulen Hatemi1 and Johannes Nowatzky4, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2NYU Grossman School of Medicine, New York, NY, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 4New York University Grossman School of Medicine, New York, NY

    Background/Purpose: The immune landscape of Behçet’s disease (BD) remains ill-defined, lacking a unifying picture, precise disease phenotype-endotype correlations, and an understanding of immunity at target…
  • Abstract Number: 0715 • ACR Convergence 2024

    Diffuse Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Revisited

    Samuel Falde1, Elif Ediboglu1, Misbah Baqir1, Rodrigo Cartin-Ceba2, Fernando C. Fervenza1, Ladan Zand1, Matthew Koster1, Kenneth Warrington1 and Ulrich Specks1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ

    Background/Purpose: We sought to characterize the most recent cohort of patients presenting with DAH and AAV and to identify risk factors for respiratory failure and…
  • Abstract Number: 0753 • ACR Convergence 2024

    Treatment and Evolution in 134 Patients with Aortitis and Periaortitis. Experience of a Single Referral Centre

    Carmen Secada Gómez1, Javier Loricera2, Adrián Martín-Gutiérrez3, Fernando Lopez-Gutierrez4, Santos Castañeda5 and Ricardo Blanco-Alonso6, 1Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Hospital Universitario Marques de Valdecilla, IDIVAL, Renedo de Piélagos, Cantabria, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 5Hospital Universitario de la Princesa, Madrid, Spain, 6Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Aortitis and periaortitis include a heterogeneous group of entities that may be idiopathic or secondary to infectious and non-infectious processes. Therefore, treatment will differ…
  • Abstract Number: 0849 • ACR Convergence 2024

    Effectiveness of Tocilizumab in Aortitis and Aneurysms Associated with Giant Cell Arteritis. Multicenter Open-label Study

    Adrián Martín-Gutiérrez1, Javier Loricera2, Carmen Secada Gómez3, Iñigo Hernández-Rodríguez4, Susana Romero Yuste5, Eugenio De Miguel6, Eva Galindez-Agirregoikoa7, ivan Ferraz-Amaro8, Julio Sánchez-Martín9, Patricia Moya Albarado10, Cristina Campos Fernández11, Fernando Lopez-Gutierrez12, Santos Castañeda13 and Ricardo Blanco-Alonso14, and the Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group, 1Hospital Universitario Marques de Valdecilla, IDIVAL, Renedo de Piélagos, Cantabria, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 4Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 5Department of Rheumatology, University Hospital Complex of Pontevedra, Pontevedra, Spain, 6Hospital Universitario La Paz, Madrid, Spain, 7BASURTO UNIVERSITY HOSPITAL, BILBAO, Spain, 8Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 9Hospital Universitario 12 de Octubre, Madrid, Spain, 10Hospital de San Pau, Barcelona, Spain, 11Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain, 12Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 13Hospital Universitario de la Princesa, Madrid, Spain, 14Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Giant Cell Arteritis (GCA) was initially described involving mainly the extracranial branches of the carotid arteries. However, GCA also may involve the aorta (GCA-aortitis)…
  • Abstract Number: 1615 • ACR Convergence 2024

    Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study

    Fatih Yildirim1, Cemal Bes2, Muhammet Emin Kutu3, Fatih Tastekin4, Gokhan Keser5, Tugba Ocak6, Ediz Dalkilic6, Yavuz Pehlivan6, Hasan Kocaayan7, Servet Akar7, Sema İsik8, Ahmet Omma9, Senar San10, Ayten Yazici11, Ayse Cefle11, Safiye Bakkal12, Gökçe Kenar13, Fatos Onen12, Aysegül Avcu14, Fatma Alibaz Öner15, Haner Direskeneli15, Burcu Ceren Uludogan16, Nazife Sule yaşar Bile16 and Nilüfer Alpay Kanıtez17, 1University of Health Sciences Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey, İstanbul, Turkey, 2University of Health Sciences Başakşehir Çam and Sakura City HospitalUniversity of Health Sciences Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey, İstanbul, Turkey, 3Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey, 4Ege University School of Medicine, Rheumatology, İzmir, Turkey, İzmir, Turkey, 5Ege University School of Medicine, Rheumatology, İzmir, Turkey, Izmir, Turkey, 6Uludağ University Faculty of Medicine, Rheumatology, Bursa, Turkey, Bursa, Turkey, 7İzmir Katip Celebi University School of Medicine, Rheumatology, İzmir, Turkey, İzmir, Turkey, 8University of Health Sciences Ankara Bilkent City Hospital, Rheumatology, Ankara, Turkey, Ankara, Turkey, 9Ankara Bilkent City Hospital, Ankara, Turkey, 10Kocaeli University Faculty of Medicine, Rheumatology, Kocaeli, Turkey, Kocaeli, Turkey, 11Kocaeli University Faculty of Medicine, Kocaeli, Turkey, Kocaeli, Turkey, 12Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, İzmir, Turkey, 13Dokuz Eylul University School of Medicine, Izmir, Turkey, 14Marmara University Faculty of Medicine, Rheumatology, İstanbul, Turkey, İstanbul, Turkey, 15Marmara University Faculty of Medicine, Rheumatology, İstanbul, Turkey, Istanbul, Turkey, 16Osmangazi University Faculty of Medicine, Rheumatology, Eskişehir, Turkey, Eskisehir, Turkey, 17Koc University Faculty of Medicine, Rheumatology, İstanbul, Turkey, Istanbul, Turkey

    Background/Purpose: The understanding of progression or minimal disease activity in patients with Takayasu arteritis (TA) can be complicated due to the possibility of mild vascular…
  • Abstract Number: 1641 • ACR Convergence 2024

    Orbital MRI as a Promising Approach for the Diagnosis of Giant Cell Arteritis in Case of Anterior Ischemic Optical Neuropathy or Central Retinal Artery Occlusion

    Guillaume BRENAC1, Angélique BERNARD1, Hélène GREIGERT1, Brivael LEMOGNE2, Andre Ramon3, Sylvain AUDIA1, Vanessa LEGUY-SEGUIN1, Jérôme RAZANAMAHERY1, Louis ARNOULD1, Catherine CREUZOT-GARCHER1, Bernard Bonnotte4 and Maxime SAMSON1, 1Dijon University Hospital, Dijon, France, 2Dijon University Hopital, Dijon, France, 3Dijon University Hospital, Besançon, France, 4Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France., Dijon, France

    Background/Purpose: Vision loss associated with acute anterior ischemic optic neuropathy (AION) or central retinal artery occlusion (CRAO) can reveal giant cell arteritis (GCA). In this…
  • Abstract Number: 2495 • ACR Convergence 2024

    Diffuse Alveolar Hemorrhage in Patient with ANCA-associated Vasculitis AndInterstitial Lung Disease

    Elif Ediboglu1, Samuel Falde1, Misbah Baqir1, Rodrigo Cartin-Ceba2 and Ulrich Specks1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ

    Background/Purpose: The association of interstitial lung disease (ILD) and microscopic polyangiitis (MPA) is increasingly recognized. The implications of ILD as it relates to clinical outcomes…
  • Abstract Number: 2519 • ACR Convergence 2024

    What Do We Know About Malignancies in IgA Vasculitis?

    Alojzija Hocevar1, Jaka Ostrovrsnik2, vesna Jurcic3 and Ziga Rotar4, 1University Medical Center Ljubljana, LJUBLJANA, Slovenia, 2UMC Ljubljana, Dpt. of Rheumatology, Ljubljana, Slovenia, 3Medical Faculty, University of Ljubljana, Institute of pathology, Ljubljana, Slovenia, 4University Medical Centre Ljubljana and University of Ljubljana, Ljubljana, Slovenia

    Background/Purpose: Cancer has been reported as a potential trigger of IgA vasculitis (IgAV) in adults, however data on this topic is scarce. The aim of…
  • 1
  • 2
  • 3
  • …
  • 35
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology